Key result
In infants under 1 year of age with supraventricular tachycardias, flecainide combined with beta-blockers was highly effective for long-term maintenance of sinus rhythm in both re-entry and automatic tachycardias.
Why the study?
No international consensus exists regarding the best drug for stable maintenance of sinus rhythm in supraventricular tachycardias during the first year of life.
Does maintenance pharmacological therapy with flecainide and beta-blockers improve long-term maintenance of sinus rhythm in infants under 1 year of age with supraventricular tachycardias?
Observational (n=55)
No
Does maintenance pharmacological therapy with flecainide and beta-blockers improve long-term maintenance of sinus rhythm in infants under 1 year of age with supraventricular tachycardias?
Answers are grounded in this paper and cite their sources.
The combination of flecainide and beta-blockers is highly effective for the long-term maintenance of sinus rhythm in infants with both re-entry and automatic supraventricular tachycardias.
BACKGROUND: Supraventricular tachycardias (SVTs) are common in the first year of life and may be life-threatening. Acute cardioversion is usually effective, with both pharmacological and non-pharmacological procedures. However, as yet no international consensus exists concerning the best drug required for a stable conversion to sinus rhythm (maintenance treatment). Our study intends to describe the experience of a single centre with maintenance drug treatment of both re-entry and automatic SVTs in the first year of life. METHODS: From March 1995 to April 2019, 55 patients under one year of age with SVT were observed in our Centre. The SVTs were divided into two groups: 45 re-entry and 10 automatic tachycardias. As regards maintenance therapy, in re-entry tachycardias, we chose to start with oral flecainide and in case of relapses switched to combined treatment with beta-blockers or digoxin. In automatic tachycardias we first administered a beta-blocker, later combined with flecainide or amiodarone when ineffective. RESULTS: The patients' median follow-up time was 35 months. In re-entry tachycardias, flecainide was effective as monotherapy in 23/45 patients (51.1%) and in 20/45 patients (44.4%) in combination with nadolol, sotalol or digoxin (overall 95.5%). In automatic tachycardias, a beta-blocker alone was effective in 3/10 patients (30.0%), however, the best results were obtained when combined with flecainide: overall 9/10 (90%). CONCLUSIONS: In this retrospective study on pharmacological treatment of SVTs under 1 year of age the combination of flecainide and beta-blockers was highly effective in long-term maintenance of sinus rhythm in both re-entry and automatic tachycardias.
No takes yet. Share an insight, caveat, or question.
Capponi et al. (2021) conducted an observational in Supraventricular tachycardias (n=55). Flecainide and beta-blockers was evaluated on Long-term maintenance of sinus rhythm. In infants under 1 year of age with supraventricular tachycardias, flecainide combined with beta-blockers was highly effective for long-term maintenance of sinus rhythm in both re-entry and automatic tachycardias.
Synapse has enriched 10 related papers. Consider them for comparative context: